linkedin post 2013-06-18 07:05:43

HALF A TRILLION DOLLARS IN SALES by Pharma companies is a whopping amount. Add to this the over 600,000 employed directly in Europe alone with a multiplier of 3-4 for upstream and downstream jobs, and you have an economic engine with horsepower. As new drug approvals are switching to biologicals, the biotech industry which feeds this will be on the ascendancy, and more Pharma companies will be forced to transition to Biopharma. This trend is in stark contrast to the current difficulty of funding early stage Biopharma. It is time for government initiatives to fill this gap.

http://www.pharmaintellect.com/2011/07/top-50-pharmaceutical-companies-in.html?m=1

View in LinkedIn